Literature DB >> 27422009

Structure-Activity Studies of β-Hairpin Peptide Inhibitors of the Plasmodium falciparum AMA1-RON2 Interaction.

Geqing Wang1, Nyssa Drinkwater2, Damien R Drew3, Christopher A MacRaild1, David K Chalmers1, Biswaranjan Mohanty1, San Sui Lim1, Robin F Anders4, James G Beeson5, Philip E Thompson1, Sheena McGowan2, Jamie S Simpson1, Raymond S Norton6, Martin J Scanlon7.   

Abstract

The interaction between apical membrane antigen 1 (AMA1) and rhoptry neck protein 2 (RON2) plays a key role in the invasion of red blood cells by Plasmodium parasites. Disruption of this critical protein-protein interaction represents a promising avenue for antimalarial drug discovery. In this work, we exploited a 13-residue β-hairpin based on the C-terminal loop of RON2 to probe a conserved binding site on Plasmodium falciparum AMA1. A series of mutations was synthetically engineered into β-hairpin peptides to establish structure-activity relationships. The best mutations improved the binding affinity of the β-hairpin peptide by ~7-fold for 3D7 AMA1 and ~14-fold for FVO AMA1. We determined the crystal structures of several β-hairpin peptides in complex with AMA1 in order to define the structural features and specific interactions that contribute to improved binding affinity. The same mutations in the longer RON2sp2 peptide (residues 2027-2055 of RON2) increased the binding affinity by >30-fold for 3D7 and FVO AMA1, producing KD values of 2.1nM and 0.4nM, respectively. To our knowledge, this is the most potent strain-transcending peptide reported to date and represents a valuable tool to characterize the AMA1-RON2 interaction.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  apical membrane antigen 1; malaria; peptide inhibitors; protein–peptide complex; structure-based ligand design

Mesh:

Substances:

Year:  2016        PMID: 27422009     DOI: 10.1016/j.jmb.2016.07.001

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  5 in total

Review 1.  Antimalarial drug discovery targeting apical membrane antigen 1.

Authors:  Shane M Devine; Christopher A MacRaild; Raymond S Norton; Peter J Scammells
Journal:  Medchemcomm       Date:  2016-11-04       Impact factor: 3.597

2.  Immunization with the Malaria Diversity-Covering Blood-Stage Vaccine Candidate Plasmodium falciparum Apical Membrane Antigen 1 DiCo in Complex with Its Natural Ligand PfRon2 Does Not Improve the In Vitro Efficacy.

Authors:  Holger Spiegel; Alexander Boes; Rolf Fendel; Andreas Reimann; Stefan Schillberg; Rainer Fischer
Journal:  Front Immunol       Date:  2017-06-27       Impact factor: 7.561

3.  Efficient refolding and functional characterization of PfAMA1(DI+DII) expressed in E. coli.

Authors:  Anamika Biswas; Sreejith Raran-Kurussi; Akash Narayan; Abhisek Kar; Purna Chandra Mashurabad; Mrinal Kanti Bhattacharyya; Kalyaneswar Mandal
Journal:  Biochem Biophys Rep       Date:  2021-02-22

Review 4.  The Cellular and Molecular Interaction Between Erythrocytes and Plasmodium falciparum Merozoites.

Authors:  Jessica Molina-Franky; Manuel Elkin Patarroyo; Markus Kalkum; Manuel Alfonso Patarroyo
Journal:  Front Cell Infect Microbiol       Date:  2022-03-31       Impact factor: 5.293

5.  Immunization of Cattle With Recombinant Structural Ectodomains I and II of Babesia bovis Apical Membrane Antigen 1 [BbAMA-1(I/II)] Induces Strong Th1 Immune Response.

Authors:  Amarin Rittipornlertrak; Boondarika Nambooppha; Anucha Muenthaisong; Nisachon Apinda; Pongpisid Koonyosying; Wanwisa Srisawat; Paweena Chomjit; Kanokwan Sangkakam; Veerasak Punyapornwithaya; Saruda Tiwananthagorn; Naoaki Yokoyama; Nattawooti Sthitmatee
Journal:  Front Vet Sci       Date:  2022-06-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.